Yi I Lin

US Patent:

6982842, Jan 3, 2006

Filed:

Jan 30, 2003

Appl. No.:

10/354768

Inventors:

Gary Gang Jing - Shakopee MN, US
Scott Douglas Ulrich - Apple Valley MN, US
Timothy Edward Langlais - Minneapolis MN, US
Yi Q. Lin - Mendota Heights MN, US

Assignee:

Seagate Technology LLC - Scotts Valley CA

International Classification:

G11B 27/36

US Classification:

360 31, 360 53, 324212

Abstract:

A method of performing predictive failure analysis (PFA) for a disc drive includes maintaining at least two primary error counts during operation of the disc drive. The primary error counts each correspond to disc drive errors associated with different attributes of the disc drive and are potentially indicative of disc drive failure. Imminent disc drive failure is predicted based upon a combination of the primary error counts.

US Patent:

20190086415, Mar 21, 2019

Filed:

Sep 21, 2018

Appl. No.:

16/138478

Inventors:

- Rochester MN, US
Michael P. Gustafson - Rochester MN, US
Yi Lin - Rochester MN, US

Assignee:

Mayo Foundation for Medical Education and Research - Rochester MN

International Classification:

G01N 33/574
A61N 5/10

Abstract:

This document provides methods and materials for treating patients following an assessment of immune subtypes such as an assessment of peripheral blood phenotypes. For example, methods and materials for treating a mammal having a medical condition after assessing a mammal's level of CD14/DR cells (e.g., CD14/DR monocytes) and level of CD4 cells (e.g., CD4 T cells) and classifying the mammal has being likely to experience a favorable or unfavorable medical outcome based at least in part on the mammal's level of CD14/DR cells and level of CD4 cells are provided.

US Patent:

20160077096, Mar 17, 2016

Filed:

May 7, 2014

Appl. No.:

14/889086

Inventors:

- Rochester MN, US
Michael P. GUSTAFSON - Rochester MN, US
Yi LIN - Rochester MN, US

International Classification:

G01N 33/574
A61N 5/10

Abstract:

This document provides methods and materials for treating patients following an assessment of immune subtypes such as an assessment of peripheral blood phenotypes. For example, methods and materials for treating a mammal having a medical condition after assessing a mammal's level of CD14+/DR− cells (e.g., CD14+/DR− monocytes) and level of CD4+ cells (e.g., CD4+ T cells) and classifying the mammal has being likely to experience a favorable or unfavorable medical outcome based at least in part on the mammal's level of CD14+/DR− cells and level of CD4+ cells are provided.

Address:

1347 Cherry Hl Rd, Mendota Heights, MN 55118

VIN:

JTEHW21A770039694

Make:

TOYOTA

Model:

HIGHLANDER HYBRID

Year:

2007